Imatinib for the adjuvant treatment of gastro-intestinal stromal tumours
| Status: |
History |
| Expected date of issue: |
TBC |
| Referral date: |
April 2009 |
| Wave: |
20 |
| Process: |
STA |
| Notes:
Cancer reform strategy Batch 6
|
| Topic area:
|
NICE project team
| Executive Lead: |
Peter Littlejohns
|
| Technical Lead: |
Panagiota Vrouchou
|
| Communications manager: |
Alice Law
|
| Project manager: |
Kate Moore
|
Provisional schedule
| Closing date for invited submissions / evidence submission: |
11 November 2009 |
| 1st appraisal committee meeting: |
24 February 2010 |
| 2nd appraisal committee meeting |
27 April 2010 |
Consultees and commentators
|
Consultees
|
Commentators (no right to submit or appeal)
|
|
Manufacturers/sponsors
Patient/carer groups
- GIST Support UK
- Sarcoma UK
Professional groups
- Royal College of Nursing
- Royal College of Pathologists
- Royal College of Physicians, Medical Oncology Joint Special Committee
- Royal College of Surgeons
- United Kingdom Oncology Nursing Society
Others
- Department of Health
- Welsh Assembly Government
|
General
- Department of Health, Social Services and Public Safety for Northern Ireland
- NHS Quality Improvement Scotland
Comparator manufacturer(s)
Relevant research groups
Evidence Review Group
- National Institute for Health Research Health Technology Assessment Programme
- West Midlands Health Technology Assessment Collaboration
Associated Guideline Groups
Associated Public Health Groups
|
|
Key documents
This page was last updated: 24 September 2010
